Remember this website is for detailed information about cancer and is a centralized cancer research hub forwarding – funneling all the information toward newer blog post to greater increase the content in future blog post. That being said, lets examine the issue…. does cholesterol reduction cause cancer? What impact does statin drugs have on you over the long term? My belief is to Keep Your Cholesterol Level In Check No Matter What!!!! Dr. Mehmet Oz explains how Artichoke Extract lowers cholesterol naturally.
If lower cholestrol levels were to increase the risk of cancer, how might it do this? The first explanation might be cholesterol is the basic building block of vitamin D…. a substance with a potent anti – cancer property, and secondly, your cells need cholestrol to metabolize in the correct manner. Some elevated risk of cancer for males with low serum cholestrol levels have been noted. What about other known cancer risk factors!!!!
The median of these studies examined is consistent with a 30% increased risk, and the answer for female is less clear, however, the risk seems to depend strongly on whether females have central or peripheral body fat. The strong influence of fat distribution in women suggest a metabolic or hormonal basis underlining the association.
The cancer most consistently associated with low serum cholesterol levels are those of colon and lung in males, and the cervix and breast (but only for females under 50 years of age) in female. With leukemia in both sexes, while in contrast, high cholesterol having a link with an increase in brain cancer. How you handle stress determines how your body handles cholesterol.
In the book: The China Study, counties with the lowest average plasma cholesterol levels, also have the lowest cancer rates. While this observation is open to a number of interpretations, it does not support the idea that low serum cholesterol is a tumor indicator. In aggregate, the trials of lipid – lowering interventions reviewed has shown an increase in cancer occurence (primarily mortality of approximately 24% in cholesterol lowered groups.
Recent evidence indicates that products in the cholesterol biosynthetic pathway affect DNA replication and cell proliferation. These findings also suggest a mechanism by which cholesterol lowering might accerelate the development of tumors already initiated. The data having been rviewed in no way suggest that “treatment of hypercholesterolemia” should not be pursued, however, in small sub populations reduction of plasma chole- sterol may lead to increased risk of cancer.